Skip to main content
Figure 3 | BMC Research Notes

Figure 3

From: Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

Figure 3

Positron emission tomography scanning after 8 months of crizotinib treatment: still complete response in the thorax but marked disease progression in the abdomen with newly appeared metastases in retroperitoneal, pelvic and inguinal lymph nodes.

Back to article page